ArticleJournal of microbiology and biotechnology2022
Myricetin Disturbs the Cell Wall Integrity and Increases the Membrane Permeability of
Article in Journal of microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- Parameter Optimization and Regulatory Mechanism of Cold Plasma Pretreatment for Enhancing Intracellular Polysaccharides Yield in Irpex lacteus.Applied biochemistry and biotechnology · 2026Article
- Drug-resistant clinicalAntimicrobial agents and chemotherapy · 2026Article
- Myricetin Exerts Antibiofilm Effects onJournal of fungi (Basel, Switzerland) · 2025Article
- Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis.International journal of molecular sciences · 2025Review
- Mutation of the Polygalacturonase GeneBiology · 2025Article
- RED light promotes flavonoid and phenolic accumulation in Cichorium spp. callus culture as anti-candida agent.Scientific reports · 2025Article
- Cylindracin, a Cys-rich protein expressed in the fruiting body of Cyclocybe cylindracea, inhibits growth of filamentous fungi but not yeasts or bacteria.FEBS open bio · 2024Article
- Magnolol from Magnolia officinalis inhibits Neopestalotiopsis ellipsospora by damaging the cell membrane.Scientific reports · 2024Article
- Antioxidant and Antifungal Properties of Cinnamon, Cloves,Pathogens (Basel, Switzerland) · 2024Article
- Taurine-mediated gene transcription and cell membrane permeability reinforced co-production of bioethanol and Monascus azaphilone pigments for a newly isolated Monascus purpureus.Biotechnology for biofuels and bioproducts · 2024Article
- Fisetin-Mediated Perturbations of Membrane Permeability and Intracellular pH inJournal of microbiology and biotechnology · 2024Article
- Review
- Biological Activity and Chemical Composition of Propolis Extracts with Potential Use in Vulvovaginal Candidiasis Management.International journal of molecular sciences · 2024Article
- Green control for inhibitingFrontiers in microbiology · 2024Article
- Potential of Flavonoids as Promising Phytotherapeutic Agents to Combat Multidrug-Resistant Infections.Current pharmaceutical biotechnology · 2024Review
- Article
- Antifungal activity and mechanism of action of natural product derivates as potential environmental disinfectants.Journal of industrial microbiology & biotechnology · 2023Review
- Effect of various concentrations of common organic solvents on the growth and proliferation ability ofPeerJ · 2023Article
- A semi purified hydroalcoholic fraction fromFrontiers in pharmacology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fungal cell wall and membrane are the principal targets of antifungals. Herein, we report that myricetin exerts antifungal activity against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.